Nektar Therapeutics

YTD

ALL

Trade Nektar Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NKTR

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.

CEO

Howard W. Robin

CEOHoward W. Robin

Employees

Employees61

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

1990

Founded1990

Employees

Employees61

NKTR Key Statistics

Market cap

744.91M

Market cap744.91M

Price-Earnings ratio

-4.61

Price-Earnings ratio-4.61

Dividend yield

—

Dividend yield—

Average volume

764.05K

Average volume764.05K

High today

—

High today—

Low today

—

Low today—

Open price

$38.70

Open price$38.70

Volume

0.00

Volume0.00

52 Week high

$66.92

52 Week high$66.92

52 Week low

$6.48

52 Week low$6.48

Stock Snapshot

With a market cap of 744.91M, Nektar Therapeutics(NKTR) trades at $36.58. The stock has a price-to-earnings ratio of -4.61.

During the trading day, Nektar Therapeutics(NKTR) stock saw an opening price of $38.70, a peak of —, and a bottom of —.

Trading volume for Nektar Therapeutics(NKTR) stock has reached 0, versus its average volume of 764.05K.

Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $66.92 and a low of $6.48.

Analyst ratings

89%

of 9 ratings

Buy

88.9%

Hold

11.1%

Sell

People also own

Based on the portfolios of people who own NKTR. This list is generated using Robinhood data, and it’s not a recommendation.